Abstract
Introduction: Some risks factors associated with COVID-19 infections were established such as coronary artery disease in patients with SARS-CoV-2 infections. The use of highly concentrated medications according to Arndt Schultz Law can induce reduction in the vital energy, leading to stagnation of Blood and propensity to have myocardial infarction even without arterial obstruction. Purpose: to demonstrate that patient with COVID-19 infection that received highly concentrated medications to treat this infection, have more propensity to develop myocardial infarction some days after the treatment instituted. Methods: through one case report of 42 years-old-male patient with history of acquired COVID-19 on January 2nd 2021. He was admitted in the hospital due to dyspnea symptoms, myalgia, and needs oxygenation. He received the medications, Ivermectin, Hydroxychloroquine, corticosteroids. After 18 days of the initial manifestations, the patient felt pain in the chest and went to the hospital and they found that his troponin was increasing gradually and after two hours of it increased many times and the physician decided to admit him again in the hospital to make more exams. The patient was submitted to catheterization and the result of this procedure were that all his coronary were in perfect state of health without any obstruction and they treated him as he had myocardial infarction. After three months, the patient went to my clinic due to post herpetic neuralgia and also to evaluate his condition and I performed the chakras’ energy centers measurement. Results: the results of this chakras’ energy centers measurement revealed that all his chakras were in the lowest level of energy (rated in one) with exception of the seventh (that was normal, rated in eight). I began his treatment using homeopathies medications according to the theory Constitutional Homeopathy of the Five Elements based on Traditional Chinese Medicine. Conclusion; the conclusion of this study is that patients treated with highly concentrated medications to treat SARS-CoV-2 infection can develop myocardial infarction even without arterial obstruction due to energy deficiency state prior to this infection and aggravated many times with to the use of any type of highly concentrated medications to treat this kind of infection, because it will reduce the vital energy that was already very low before the infection and will cause stagnation of Blood in any part of the body, in this case, inside the coronary artery.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Clinical Cardiology and Cardiovascular Interventions
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.